• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Federal Panel Scales Back MU Stage 3

Article

Members of the Health IT Policy Committee approved a set of recommendations Tuesday that will bring meaningful use Stage 3 requirements one step closer to federal approval and scale back the initial Stage 3 proposals by 33%.

Members of the Health IT Policy Committee approved a set of recommendations Tuesday that will bring meaningful use Stage 3 requirements one step closer to federal approval and scale back the initial Stage 3 proposals by 33 percent.

Leaving 19 measures as part of the proposal, the recommendations, presented as a Stage 3 matrix developed by the meaningful use workgroup, will be sent on to Kathleen Sebelius, secretary of Health and Human Services for consideration in developing the final Stage 3 MU requirements. More public hearings and a notice of proposed rulemaking to inform HHS’s final requirements are expected to follow in 2015.

Read the full story here: http://bit.ly/Ptfs7h

Source: Healthcare IT News

Related Videos
David Awad, PharmD, BCOP
Screenshot of Coral Omene, MD, PhD
Samir Shah, MD, MMM, FACR
Jill Feldman, patient, cofounder and president, EGFR Resisters
Eileen Peng, PharmD, sitting for a video interview
Cathy Eng, MD, FACP, FASCO
Eileen Peng, PharmD, sitting for a video interview
Christine Funke, MD
Nini Wu, MD, Navista
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.